| 000 | 01597 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513211048.0 | ||
| 264 | 0 | _c20000524 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a1565-1088 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKauli, R | |
| 245 | 0 | 0 |
_aDelayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy. _h[electronic resource] |
| 260 |
_bThe Israel Medical Association journal : IMAJ _cFeb 2000 |
||
| 300 |
_a158-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGaucher Disease _xcomplications |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGlucosylceramidase _xtherapeutic use |
| 650 | 0 | 4 |
_aGrowth Disorders _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsrael _xepidemiology |
| 650 | 0 | 4 |
_aJews _xstatistics & numerical data |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPuberty, Delayed _xepidemiology |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSplenectomy |
| 700 | 1 | _aZaizov, R | |
| 700 | 1 | _aLazar, L | |
| 700 | 1 | _aPertzelan, A | |
| 700 | 1 | _aLaron, Z | |
| 700 | 1 | _aGalatzer, A | |
| 700 | 1 | _aPhillip, M | |
| 700 | 1 | _aYaniv, Y | |
| 700 | 1 | _aCohen, I J | |
| 773 | 0 |
_tThe Israel Medical Association journal : IMAJ _gvol. 2 _gno. 2 _gp. 158-63 |
|
| 999 |
_c10756822 _d10756822 |
||